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Antimicrobial Nodule-Specific Cysteine-Rich Peptides Induce
Membrane Depolarization-Associated Changes in the Transcriptome
of Sinorhizobium meliloti
Hilda Tiricz,a Attila Szu˝cs,a Attila Farkas,a Bernadett Pap,a Rui M. Lima,a Gergely Maróti,a Éva Kondorosi,a,b Attila Kereszta
Institute of Biochemistry, Biological Research Center, Hungarian Academy of Sciences, Szeged, Hungarya; Institut des Sciences du Végétal—CNRS, Gif-sur-Yvette,
Franceb
Leguminous plants establish symbiosis with nitrogen-fixing alpha- and betaproteobacteria, collectively called rhizobia, which
provide combined nitrogen to support plant growth. Members of the inverted repeat-lacking clade of legumes impose terminal
differentiation on their endosymbiotic bacterium partners with the help of the nodule-specific cysteine-rich (NCR) peptide fam-
ily composed of close to 600 members. Among the few tested NCR peptides, cationic ones had antirhizobial activity measured by
reduction or elimination of the CFU and uptake of the membrane-impermeable dye propidium iodide. Here, the antimicrobial
spectrum of two of these peptides, NCR247 and NCR335, was investigated, and their effect on the transcriptome of the natural
target Sinorhizobiummelilotiwas characterized. Both peptides were able to kill quickly a wide range of Gram-negative and
Gram-positive bacteria; however, their spectra were only partially overlapping, and differences were found also in their efficacy
on given strains, indicating that the actions of NCR247 and NCR335 might be similar though not identical. Treatment of S. meli-
loti cultures with either peptide resulted in a quick downregulation of genes involved in basic cellular functions, such as tran-
scription-translation and energy production, as well as upregulation of genes involved in stress and oxidative stress responses
andmembrane transport. Similar changes provokedmainly in Gram-positive bacteria by antimicrobial agents were coupled
with the destruction of membrane potential, indicating that it might also be a common step in the bactericidal actions of
NCR247 and NCR335.
The introduction of antibiotics into medical practices duringthe first half of the last century revolutionized the treatment of
infectious diseases caused by bacteria. However, the intensive use
of these drugs led to the widespread emergence of antibiotic-re-
sistant bacteria, and nowadays the general presence of these mul-
tiresistant microbes has become a major problem in public health
therapy (1). This necessitates urgent development of new genera-
tions of antibacterial agents with novelmodes of action that can be
effective also in the case of multiresistant microbes (2).
Nearly all organisms, including bacteria, fungi, plants, and an-
imals, produce antimicrobial peptides (AMPs) that are ribo-
somally synthesized natural antibiotics. AMPs are the effector
molecules of the innate immunity in plants and animals and are
able to kill microbes; however, they can fulfill signaling functions
as well. Themost general mode of their antimicrobial action is the
disruption of the microbial membranes or the formation of pores
that ultimately will also lead to cell lysis. However, a growing body
of evidence suggests that AMPs, by entering the cell, can have
intracellular targets (3). A recent development in genomics (high-
throughput sequencing of genomes and transcriptomes) revealed
large numbers of genes (up to several hundred) coding for AMP-
like proteins/peptides in different eukaryotic genomes, especially
in plants.
The genome of legumes like alfalfa, pea, or lentil belonging to
the inverted repeat-lacking clade (IRLC) in the Fabaceae/Legumi-
nosae family harbors a gene family that codes for secreted nodule-
specific cysteine-rich (NCR) peptides that are reminiscent of as
well as distinct from defensins, the largest group of plant AMPs
(4). The common features of the two families are the small size of
peptides and the disulfide bridges that stabilize their structure,
while the differences include the number of cysteines and the
charge of the peptides. NCRs can be anionic, neutral, and cationic
and contain 4 or 6 cysteines, compared to 8 cysteines in plant and
6 cysteines in vertebrate defensins, which are all cationic mole-
cules (5, 6). In the model legume Medicago truncatula (a diploid
relative of the cultivated alfalfa, Medicago sativa), there are more
than 500 NCR genes (7). These small genes usually contain two
exons: the first one codes for a relatively conserved signal peptide,
while the second one codes for the mature active peptide. The
peptides are highly divergent in amino acid composition; only 4 or
6 cysteines at given positions are conserved. These AMP-like pep-
tides are produced solely in a symbiotic organ, the root nodule,
which is formed in symbiosis by legume plants to host Rhizobium
soil bacteria. In the nodules, the plant cells are invaded with rhi-
zobia, which by maturation of the symbiotic cell differentiate to
nitrogen-fixing bacteroids, reducing atmospheric nitrogen to am-
monia and providing nitrogen nutrient for the plant (8). Expres-
sion of NCR genes requiring the presence of the endosymbiont
Sinorhizobium meliloti is activated only in the symbiotic cells. In
M. truncatula, NCR transcripts represent about 5% of the nodule
transcriptome (9). Earlier, it was shown that NCR peptides direct
an irreversible, terminal differentiation process of bacteria result-
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ing in enlargement and branching of nitrogen-fixing bacteroids
coupled to their genome amplification, membrane permeabiliza-
tion, and irreversible loss of their cell division ability (10). The ex
planta bactericidal effects of certain cationic NCRs have also been
demonstrated on the free-living S. meliloti cultures.
The aims of this study were to determine whether cationic
NCRs have antibacterial activities on bacteria other than rhizobia,
including Gram-negative and Gram-positive human/animal and
plant pathogens, and to get an insight into the NCR-provoked
global gene expression changes in S. meliloti.
MATERIALS AND METHODS
Bacterial strains and growth conditions.Bacterial strains were grown on
LB plates or in liquid medium: S. meliloti strain 1021, Listeria monocyto-
genes, Xanthomonas campestris, Clavibacter michiganensis, Agrobacterium
tumefaciens, Pseudomonas aeruginosa, and Pseudomonas syringae at 30°C
and Enterococcus faecalis, Salmonella enterica serovar Typhimurium,
Staphylococcus aureus, Escherichia coli, Bacillus megaterium, and Bacillus
cereus at 37°C. For the transcriptome analysis, S. meliloti was grown and
treated in LSM (11) liquid medium from which methionine and arginine
were omitted but was supplemented with 0.01% (wt/vol) yeast extract.
Measurement of in vitroNCRpeptide activities.Bacterial cultures in
the exponential growth phase were rediluted and grown to early logarith-
mic phase (optical density at 600 nm [OD600] 0.1) and then collected,
washed, and resuspended in 10 mM potassium-phosphate buffer (pH
7.0) to the same optical density.
To investigate the bactericidal effect of the chemically synthetizedma-
ture NCR247 (NH2-RNGCIVDPRCPYQQCRRPLYCRRR, pI  10.15)
and NCR335 (NH2-RLNTTFRPLNFKMLRFWGQNRNIMKHRGQKV
HFSLILSDCKTNKDCPKLRRANVRCRKSYCVPI, pI 11.22) peptides,
serial dilutions of the bacterial suspensions treated at different concentra-
tions for various time periods were plated to determine the number of
surviving cells.
To check whether the peptides affectmembrane integrity, we followed
the uptake of the membrane-impermeable DNA-binding dye propidium
iodide (PI). Bacteria were treated in Fluotrac 200 (Greiner Bio-One) mi-
crotiter plates in the presence of 5g/ml PI. PI uptake was detected by the
fluorescence (excitation of 530 nm, emission of 600 nm) of its DNA-
bound form measured in a fluorescence plate reader (FLUOstar Optima
from BMG Labtech).
Preparation of RNA samples. Bacterial cultures in the exponential
growth phasewere rediluted and grown to early logarithmic phase (OD600
0.1) in the modified LSM medium in a 40-ml volume, and then sterile
water (untreated control), NCR247, or NCR335 was added to a final con-
centration of 10 g/ml. Three biological replicates from each treatment
were incubated with vigorous shaking for 10 and 30 min. Total RNA was
purified from samples using the RiboPure-Bacteria kit (Ambion). Resid-
ual DNA was removed by using RQ1 RNase-free DNase (Promega). Each
RNA sample was divided: one half was kept for the validation experi-
ments, while the other part was processed for the transcriptome analysis.
Transcriptome analysis byRNA-Seq.For sequencing, theRNAs from
the three biological replicates were pooled. Before library preparation,
ribosomal RNAswere removed using the Ribo-Zero rRNA removal kit for
Gram-negative bacteria (Epicentre). Library preparation and RNA se-
quencing (RNA-Seq) were performed by using the dedicated kits and the
SOLiD4 sequencer (Life Technologies), respectively. We generated 20 to
25 million 50-nucleotide-long reads per sample, from which approxi-
mately 45% proved to be quality data and thus could be mapped onto the
S. meliloti genome (12).
Bioinformatic analysis. Basic bioinformatic analyses (mapping of
reads to the reference genome, normalization, calculation of expression
values) were performed with the help of the CLC Genomic Workbench
software. Reads mapping to tRNA and rRNA were removed from further
analysis. We omitted the genes from further analysis if their expression
was lower than 10 reads per 1 million mRNA reads. To identify up- and
downregulated genes, RPKMvalues (reads per kilobase of genemodel per
millionmapped reads) were compared. For pathway analysis, we used the
KEGG database (http://www.genome.jp/kegg/).
Validation of the sequencing data.To validate the sequencing results,
quantitative reverse transcription-PCR (qRT-PCR) was performed on se-
lected genes by using the primers shown in Table S1 in the supplemental
material and rRNA as a reference, and then the results were compared to
the sequencing data. RNA was reverse transcribed by the high-capacity
cDNA reverse transcription kit (Life Technologies). PCR amplification
was performed using the Power SYBR green kit (Life Technologies) and
detected by the incorporation of the SYBR green dye in a StepOne real-
time PCR system using StepOne software version 2.1 (Life Technologies).
Two technical replicates were performed on all biological replicates.
RNA-Seq data accession number. The RNA-Seq data have been de-




andNCR335 peptides decreased the living cell number of the sym-
biotic S. meliloti bacteria by three and four orders of magnitude,
respectively, when107 bacteria were exposed in vitro to the pep-
tides at the concentration of 50 g/ml for 3 h (Fig. 1). To investi-
gate whether these compounds have an antibacterial effect on dif-
ferent Gram-negative (E. coli, S. Typhimurium, A. tumefaciens, P.
aeruginosa, X. campestris) and Gram-positive (B. megaterium, B.
cereus, C. michiganensis, S. aureus, L. monocytogenes) bacteria, in-
cluding human/animal and plant pathogens, these microorgan-
isms were treated similarly with 50 g/ml of the NCR247 and
NCR335 peptides, and the number of surviving cells was deter-
mined by counting the CFU. Figure 1 shows that both peptides,
although having different spectrums, decreased the living cell
number of all tested bacteria from at least one order of magnitude
to their complete elimination. Two plant-pathogenic microor-
ganisms,X. campestris andC.michiganensis, were particularly sen-
sitive toward both peptides, while A. tumefaciens and L. monocy-
togenes expressed moderate resistance against them, as 0.01 to 5%
of the cells survived the exposure to the peptides. S. Typhimurium
and S. aureus were effectively killed by NCR247, while B. megate-
rium,E. coli,B. cereus, andP. aeruginosawere sensitive toNCR335.
Transcriptome analysis of NCR-treated cells. To investigate
the early global gene expression changes in S. meliloti, the natural
target of the NCR peptides, in response to NCR247 or NCR335 in
vitro, genome-wide transcriptome profiling was performed by the
RNA-Seq method (13). Exponentially growing cells were sub-
jected to the peptides at a concentration of 10g/ml for 10 and 30
min. At these periods of treatments, NCR247 exposure did not
affect colony-forming (surviving or cell division) ability, while
NCR335 treatments reduced the CFU value to 66 and 57% of that
of the untreated cultures, indicating that the antirhizobial poten-
tial of NCR335 is higher than that of NCR247. A total of 120 min
of exposure, however, severely affected the colony-forming rate
(NCR247, 8.1%; NCR335, 9.5%). At 30 min, the uptake of the
membrane-impermeable dye propidium iodide (PI) was not de-
tected in the case of NCR247 (see Fig. S1 in the supplemental
material), indicating that drastic alteration or disintegration of the
bacterial membranes had not started yet.
RNA samples isolated from the bacteria after the 10 and 30min
of treatments were used for RNA-Seq. In total, differential expres-
sion of 879 genes (representing 14% of the predicted protein-
coding sequences in the S. meliloti 1021 genome) could be ob-
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served at a 2-fold cutoff: 366 genes were downregulated, while 543
genes were upregulated (see Table S2 in the supplemental mate-
rial). NCR335 affected a higher number of genes than NCR247,
causing down- and upregulation of 319 and 418 genes, respec-
tively. In the case of NCR247 treatment, 153 genes were down-
regulated and 242 genes were upregulated. The numbers of genes
that differentially expressed in single or multiple samples are
shown in the Venn diagrams of Fig. 2. To validate the RNA-Seq
data, real-time qRT-PCR experiments were performed using the
RNA samples that had been used for sequencing. The results of the
qRT-PCR experiments confirmed the up- or downregulation of
the selected genes (Fig. 3).
No overlap between the up- and downregulated genes was no-
ticed, i.e., none of the genes upregulated by one peptidewas down-
regulated by the other one at any time point. First, we looked for
genes that were specifically regulated by one of the peptides. For
this purpose, genes were investigated individually by comparing
their expression in both peptide treatments at both time points. In
the case of most responding genes, the treatments resulted in sim-
ilar expression changes, though the threshold was not crossed in
all four samples. Such genes, i.e., those that showed an above-
threshold increase or decrease in certain samples and between 1.3-
and 2-fold up- or downregulation in the others, were discussed
among the generally down- and upregulated functions (Table 1).
Peptide-specific up- and downregulated genes.NCR247 spe-
cifically downregulated the expression of the SMc04329 gene cod-
ing for a conserved ferredoxin-like hypothetical protein and up-
regulated 11 genes coding, for example, for sulfite oxidase
subunits YedYZ, the substrate-binding protein precursor of an
iron uptake ABC transporter, as well as the ExbBD proteins that,
in complex with TonB, transduce energy to TonB-dependent
transporters, facilitating mainly the uptake of iron complexes
(14). NCR335 specifically downregulated the expression of seven
open reading frames (ORFs) coding for hypothetical proteins, one
gene coding for a fatty acid desaturase, themucR gene coding for a
transcription factor, and fiveORFs coding for proteins involved in
RNAmetabolism, such as the RNA chaperons Csp1, -4, -A2, -A8,
and RNaseP. The 59 genes that were specifically upregulated by
NCR335 have the coding capacity for 32 hypothetical proteins,
one stomatin-like membrane protein, one oxidoreductase do-
main-containing protein, one plasmid stability protein, and one
cyclopropane-fatty-acyl-phospholipid synthase involved inmem-
brane modifications. Of the remaining encoded proteins, three
enzymes are involved in the degradation of AMP to urate, and
FIG 1 Antibacterial activity of NCR247 (a) and NCR335 (b) peptides. Cell survival is shown as the number of colonies formed (CFU) from 108 cells treated for
3 h with peptides at a concentration of 50 g/ml.
FIG 2 The number of the at-least-two-times downregulated (a) and upregulated (b) genes after 10 (I, II) and 30 (III, IV) min of treatment with the NCR247 (I,
III) and NCR335 (II, IV) peptides.
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three proteins compose the glycine cleavage system that contrib-
utes to the pool of compounds containing only one carbon. The
largest groups of the NCR335-induced genes encoding proteins
with known/predicted roles belong to functional categories of
transcriptional regulation (9 genes) and membrane transport (8
genes). Interestingly, four genes coding for transcriptional regu-
lators (TRs) were linked to operons/genes involved in the produc-
tion of seven (ABC-type)membrane transporters (MTs) thatwere
also induced by the peptide, raising the possibility that these tran-
scription factors directly regulate the expression of the neighbor-
ing genes.
Generally downregulated functions.We looked for enriched
functional categories and pathways among the products of those
genes that showed differential expression. It is worth mentioning
that NCR335, which is more potent in its antirhizobial activity
thanNCR247, often causedmore pronounced expression changes
than the other peptide. A good portion of the downregulated
functions affected genetic information processing (Table 1). The
expression of genes coding for proteins involved in transcription,
such as the RNA-polymerase subunits (RpoABCZ) and the tran-
scription terminator (Rho) and antiterminator (NusG) proteins,
was reduced. Factors involved in translation, like translation ini-
tiation factors (IF-1, -2, -3), elongation factors (G, P, Tu1, Tu2,
Ts), the ribosome-associated chaperone trigger factor (Tig), and
genes coding for all (Rps, Rpm, and Rpl) ribosomal subunits and
proteins predicted to function in ribosome biogenesis (HflX,
EngD), also showed decreased transcript levels. In addition, pro-
teins participating in conformational modification, metabolism,
or maturation of RNAmolecules (ATP-dependent RNA helicases
RhlE1 and RhlE2, RNase E, polynucleotide phosphorylase/poly-
adenylase Pnp) also had decreased expression. The expression of
genes coding for enzymes participating in the early, common steps
of purine and thiamine biosynthesis was also reduced, as well as
the transcription of the ndk gene encoding the nucleoside-diphos-
phate kinase catalyzing the exchange of phosphate groups be-
tween different nucleoside diphosphates. Furthermajor biochem-
ical functions that are downregulated by the peptides are oxidative
phosphorylation and fatty acid biosynthesis: all genes coding for
the elements of the FoF1 ATP synthase and cytochrome bc1 com-
plex, as well as six genes coding for fatty acid biosynthetic en-
zymes, showed decreased expression. Certain ABC transporter
genes, including the ones implicated in heavy metal (cadmium)
and spermidine/putrescine export, were also inhibited (Table 1).
Generally upregulated functions. Among the upregulated
genes, 15 sequences coding for stress-related functions were iden-
tified: the highest induction was observed in the case of the ibpA,
rpoH1, andmsrA1 genes coding for a heat shock protein, an RNA
polymerase sigma factor, and methionine sulfoxide reductase A
(Table 1). The msrA and the clpB and hslV genes encoding ATP-
dependent proteases were also induced. The upregulation of other
heat shock proteins (Hsp20s, GroES, GroEL, DnaJ, SMc01106)
and protease (DegP3)-coding genes were less pronounced;
though NCR247 increased their transcription, this increase
crossed the threshold only in the case of NCR335 treatment. Sim-
ilarly to the NCR335-specific changes, a high number of upregu-
lated genes encodedMTs (35 genes) as well as TRs (15 genes), and
four TR-coding genes were linked to peptide-induced MT oper-
ons/genes. We do not know the substrate for most of the upregu-
lated membrane transporters, except for ZnuABC mediating
high-affinity zinc uptake (regulated by the induced Zur transcrip-
FIG 3 Validation of the RNA-Seq results. Expression of selected genes relative to the rRNA level in RNA samples from bacteria treated with NCR247 (a, c) and
NCR335 (b, d) for 10 (a, b) and 30 (c, d) min was determined by qRT-PCR (dark-gray columns) and compared to values obtained by RNA-Seq (light-gray
columns).
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TABLE 1 Selected S. meliloti genes regulated differentially by the NCR peptides
Category and gene Putative function
Fold change
10 min 30 min
NCR247 NCR335 NCR247 NCR335
Genes encoding proteins involved in transcriptional regulation
SMa1207 Crp family transcriptional regulator 0.45 0.17 0.50 0.44
SMc01468 Chemotaxis protein 0.73 0.39 0.62 0.47
SMc02521 Glycerol-3-phosphate regulon repressor transcription
regulator protein
1.91 2.48 1.72 2.15
SMc03806 Nitrogen regulatory protein PII 2 1.54 4.66 2.01 3.56
SMa0160 GntR family transcriptional regulator 3.21 2.87 2.39 1.92
SM_b20215 Transcriptional regulator protein 1.65 3.20 1.91 2.38
SMa0961 Response regulator 0.70 1.69 2.03 2.99
SMa1056 Transcriptional regulator 0.86 1.98 2.13 2.67
SMa5007 Transcriptional regulator 1.41 3.25 1.87 3.47
SMc00129 Sensor histidine kinase 1.98 1.99 2.12 2.13
SMc00329 Iron response regulator protein 1.25 2.10 1.44 2.22
SMc00458 Transcription regulator protein 2.45 2.86 2.31 2.29
SMc02584 Transcription regulator protein 1.17 2.11 1.38 2.43
SMc02876 Transcription regulator protein 1.59 2.23 2.13 2.30
SMc02888 Transcription regulator protein 2.85 2.08 3.05 2.00
SMc04203 RNA polymerase sigma factor FECI protein 1.49 1.91 2.55 2.68
SMc04242 Zinc uptake regulation protein 6.04 5.23 2.44 2.98
SM_b20344 Transcriptional regulator protein 1.06 3.41 0.73 2.08
SM_b21115 Response regulator protein 0.90 2.25 1.06 2.03
SM_b21706 LacI family transcriptional regulator 0.75 2.32 1.04 2.03
SMa0402 GntR family transcriptional regulator 1.15 2.51 1.04 2.06
SMc00562 Transcription regulator protein 1.95 10.61 1.08 6.65
SMc00653 Two-component receiver domain protein 1.01 2.19 0.81 2.22
SMc03169 Transcription regulator protein 1.74 4.39 0.79 2.48
SMc03824 Transcription regulator protein 1.29 3.16 0.73 2.28
SMc03949 Nitrogen regulatory protein 1.19 2.13 0.98 2.76
SMc00646 RNA polymerase factor sigma-32 2.16 2.44 2.23 2.25
Genes encoding proteins involved in transcription
SMc01285 DNA-directed RNA polymerase subunit alpha 0.48 0.19 0.42 0.22
SMc01316 DNA-directed RNA polymerase subunit beta= 0.54 0.41 0.46 0.38
SMc01317 DNA-directed RNA polymerase subunit beta 0.47 0.29 0.44 0.36
SMc02408 DNA-directed RNA polymerase subunit omega 0.81 0.39 0.62 0.32
SMc01322 Transcription antitermination protein NusG 0.60 0.32 0.88 0.42
SMc02796 Transcription termination factor Rho 0.76 0.35 0.61 0.35
Genes encoding proteins involved in conformational
modification, metabolism, or maturation of RNA
SMa0126 Cold shock family protein 0.92 0.32 1.04 0.31
SMc01428 Cold shock transcription regulator protein 1.06 0.37 1.26 0.47
SMc04234 Cold shock-like transcription regulator protein 0.96 0.42 1.02 0.43
SMc04318 Cold shock transcription regulator protein 0.85 0.46 0.77 0.37
SMc00324 Polynucleotide phosphorylase/polyadenylase 0.51 0.28 0.35 0.24
SM_b20880 ATP-dependent RNA helicase 0.71 0.21 0.57 0.21
SMc00522 ATP-dependent RNA helicase 0.54 0.25 0.57 0.34
SMc01720 RNase P 0.57 0.24 0.41 0.34
SMc01336 RNase E protein 1.00 0.46 0.81 0.39
SMc01327 tRNA/rRNA methyltransferase 0.73 0.41 0.68 0.47
Genes encoding subunits of and proteins involved in
biogenesis of ribosomes
SMc01049 GTP-binding protein 0.72 0.42 0.74 0.42
SMc02695 GTP-dependent nucleic acid-binding protein EngD 0.64 0.41 0.59 0.50
SM_b20995 GTP-binding protein EngA 0.48 0.39 0.61 0.45
SMc00323 30S ribosomal protein S15 0.48 0.28 0.48 0.32
SMc00335 30S ribosomal protein S1 0.43 0.26 0.33 0.23
SMc00363 50S ribosomal protein L35 0.49 0.25 0.83 0.36
SMc00364 50S ribosomal protein L20 0.51 0.19 0.40 0.24
SMc00485 30S ribosomal protein S4 0.35 0.16 0.45 0.22
SMc00565 50S ribosomal protein L9 0.31 0.19 0.23 0.21
SMc00567 30S ribosomal protein S18 0.35 0.16 0.36 0.23
SMc00568 30S ribosomal protein S6 0.37 0.21 0.41 0.29
SMc00704 50S ribosomal protein L28 0.51 0.29 0.57 0.37
SMc01152 30S ribosomal protein S20 0.45 0.24 0.58 0.25
SMc01283 50S ribosomal protein L17 0.57 0.24 0.43 0.22
SMc01286 30S ribosomal protein S11 0.50 0.18 0.41 0.19
SMc01287 30S ribosomal protein S13 0.53 0.26 0.61 0.32
SMc01290 50S ribosomal protein L15 0.37 0.23 0.30 0.22
SMc01291 50S ribosomal protein L30 0.36 0.16 0.22 0.16
SMc01292 30S ribosomal protein S5 0.36 0.17 0.23 0.19
SMc01293 50S ribosomal protein L18 0.34 0.25 0.27 0.22
SMc01294 50S ribosomal protein L6 0.34 0.23 0.29 0.21
SMc01295 30S ribosomal protein S8 0.29 0.16 0.25 0.17
SMc01296 30S ribosomal protein S14 0.32 0.19 0.26 0.17
SMc01297 50S ribosomal protein L5 0.33 0.16 0.30 0.22
SMc01298 50S ribosomal protein L24 0.30 0.15 0.31 0.24
(Continued on following page)
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TABLE 1 (Continued)
Category and gene Putative function
Fold change
10 min 30 min
NCR247 NCR335 NCR247 NCR335
SMc01299 50S ribosomal protein L14 0.40 0.20 0.32 0.23
SMc01300 30S ribosomal protein S17 0.31 0.30 0.27 0.23
SMc01301 50S ribosomal protein L29 0.38 0.26 0.28 0.21
SMc01302 50S ribosomal protein L16 0.34 0.24 0.28 0.20
SMc01303 30S ribosomal protein S3 0.29 0.27 0.25 0.25
SMc01304 50S ribosomal protein L22 0.30 0.26 0.20 0.23
SMc01305 30S ribosomal protein S19 0.25 0.21 0.22 0.19
SMc01306 50S ribosomal protein L2 0.28 0.19 0.21 0.18
SMc01307 50S ribosomal protein L23 0.28 0.23 0.29 0.22
SMc01308 50S ribosomal protein L4 0.27 0.23 0.20 0.23
SMc01309 50S ribosomal protein L3 0.27 0.16 0.21 0.16
SMc01310 30S ribosomal protein S10 0.29 0.16 0.21 0.19
SMc01313 30S ribosomal protein S7 0.37 0.17 0.32 0.22
SMc01314 30S ribosomal protein S12 0.41 0.17 0.41 0.21
SMc01318 50S ribosomal protein L7/L12 0.36 0.23 0.35 0.23
SMc01319 50S ribosomal protein L10 0.35 0.20 0.36 0.19
SMc01320 50S ribosomal protein L1 0.41 0.21 0.42 0.23
SMc01321 50S ribosomal protein L11 0.43 0.16 0.41 0.22
SMc01369 50S ribosomal protein L33 0.67 0.27 0.59 0.31
SMc01803 30S ribosomal protein S9 0.43 0.44 0.45 0.57
SMc01804 50S ribosomal protein L13 0.46 0.41 0.46 0.34
SMc02101 30S ribosomal protein S2 0.46 0.31 0.44 0.36
SMc02692 50S ribosomal protein L25 0.34 0.20 0.42 0.24
SMc03770 50S ribosomal protein L21 0.56 0.27 0.73 0.36
SMc03772 50S ribosomal protein L27 0.45 0.23 0.63 0.39
SMc03859 30S ribosomal protein S16 0.56 0.33 0.54 0.36
SMc03863 50S ribosomal protein L19 0.55 0.28 0.40 0.34
SMc03881 50S ribosomal protein L32 0.54 0.24 0.63 0.36
SMc03990 50S ribosomal protein L31 0.59 0.16 0.62 0.25
SMc04003 50S ribosomal protein L36 0.55 0.21 0.72 0.33
SMc04003 50S ribosomal protein L36 0.55 0.21 0.72 0.33
SMc04320 30S ribosomal protein S21 1.07 0.37 1.01 0.36
SMc04434 50S ribosomal protein L34 0.54 0.20 0.86 0.25
Genes encoding proteins involved in translation
SMc00357 Elongation factor P 0.51 0.22 0.51 0.24
SMc01311 Elongation factor Tu 0.35 0.23 0.27 0.20
SMc01312 Elongation factor G 0.31 0.19 0.26 0.22
SMc01326 Elongation factor Tu 0.36 0.22 0.28 0.21
SMc02100 Elongation factor Ts 0.50 0.35 0.33 0.30
SMc02310 Translation initiation factor IF-1 0.65 0.38 0.73 0.44
SMc02914 Translation initiation factor IF-2 0.78 0.50 0.61 0.38
SMc00362 Translation initiation factor IF-3 0.80 0.39 0.87 0.42
SMc02050 Trigger factor 0.52 0.22 0.46 0.26
SMc01700 Peptidyl-prolyl cis-trans isomerase A signal peptide protein 0.83 0.42 0.78 0.45
Genes encoding proteins involved in purine/pyrimidine
metabolism
SM_b21284 Uricase 0.66 2.95 1.48 2.48
SM_b21286 Xanthine dehydrogenase 0.72 2.12 0.92 2.03
SMc02386 AMP nucleosidase 1.33 2.27 1.11 2.16
SMc01215 Carbamoyl phosphate synthase large subunit 0.50 0.39 0.61 0.51
SMc01569 Carbamoyl phosphate synthase small subunit 0.55 0.36 0.57 0.49
SMc00488 Phosphoribosylformylglycinamidine synthase II 0.62 0.49 0.63 0.46
SMc00495 Phosphoribosylaminoimidazole-succinocarboxamide synthase 0.59 0.27 0.56 0.30
SMc00508 Adenylosuccinate lyase 0.56 0.46 0.61 0.47
SMc00615 Phosphoribosylaminoimidazole synthetase 0.51 0.46 0.59 0.44
SMc00494 Phosphoribosylformylglycinamidine synthase subunit PurS 0.56 0.23 0.48 0.30
SMc01288 Adenylate kinase 0.56 0.40 0.72 0.37
SMc00595 Nucleoside diphosphate kinase 0.43 0.22 0.47 0.21
SMc02099 Uridylate kinase 0.49 0.49 0.78 0.59
SMc01815 Dihydropyrimidine dehydrogenase 4.07 7.42 2.96 4.05
Genes encoding proteins involved in oxidative
phosphorylation and electron transport
SMc00187 Ubiquinol-cytochrome c reductase iron-sulfur subunit protein 0.58 0.28 0.57 0.46
SMc00188 Cytochrome b transmembrane protein 0.55 0.36 0.56 0.41
SMc00189 Cytochrome c1 protein 0.54 0.47 0.45 0.35
SMc02897 Cytochrome c transmembrane protein 0.68 0.45 0.66 0.41
SMc00868 FoF1 ATP synthase subunit B 0.51 0.31 0.52 0.34
SMc00869 FoF1 ATP synthase subunit B= 0.49 0.34 0.54 0.39
SMc00870 FoF1 ATP synthase subunit C 0.36 0.31 0.49 0.32
SMc00871 FoF1 ATP synthase subunit A 0.36 0.27 0.57 0.33
SMc02498 FoF1 ATP synthase subunit delta 0.67 0.30 0.79 0.46
SMc02499 FoF1 ATP synthase subunit alpha 0.50 0.38 0.40 0.38
SMc02500 FoF1 ATP synthase subunit gamma 0.44 0.44 0.37 0.36
SMc02501 FoF1 ATP synthase subunit beta 0.49 0.57 0.43 0.41
(Continued on following page)
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TABLE 1 (Continued)
Category and gene Putative function
Fold change
10 min 30 min
NCR247 NCR335 NCR247 NCR335
SMc02502 FoF1 ATP synthase subunit epsilon 0.53 0.52 0.46 0.47
SMc03239 Inorganic pyrophosphatase 0.85 0.44 0.74 0.43
Genes encoding proteins involved in fatty acid synthesis and
metabolism and membrane modification
SMa0335 3-Ketoacyl-ACP reductase 1.27 5.13 2.99 5.69
SMc00262 Acetyl-coenzyme A (CoA) acetyltransferase 2.20 2.38 1.87 2.22
SMc00976 Enoyl-CoA hydratase 2.33 2.04 1.51 1.22
SMc02162 Long-chain fatty-acid–CoA ligase 2.47 2.42 1.95 1.64
SMc02227 Enoyl-COA hydratase 3.45 5.33 1.56 2.21
SMc02228 Acetyl-CoA acetyltransferase 3.17 4.00 1.53 1.67
SMc02229 Acyl-CoA dehydrogenase 3.21 3.48 1.36 1.36
SMc03836 Acyl-CoA thioesterase i protein 1.42 4.58 1.77 4.67
SMc04041 Lysophospholipase L2 protein 1.71 3.07 1.87 2.97
SMc01784 Glycerol-3-phosphate acyltransferase PlsX 0.76 0.42 0.69 0.47
SMc01270 Glutathione-dependent formaldehyde dehydrogenase 0.59 0.44 0.74 0.42
SMc00005 Enoyl-ACP reductase 0.52 0.28 0.62 0.32
SMc00573 Acyl carrier protein 0.59 0.49 0.61 0.47
SMc00574 3-Oxoacyl-ACP synthase 0.65 0.46 0.71 0.49
SMc01344 Acetyl-CoA carboxylase biotin carboxyl carrier protein subunit 0.90 0.39 0.74 0.45
SMc04278 Acyl carrier protein 0.59 0.40 0.60 0.45
SMc02520 Glycerol-3-phosphate dehydrogenase 2.84 2.53 2.03 2.07
SMc02645 Cyclopropane-fatty-acyl-phospholipid synthase 1.03 3.50 1.23 2.53
Genes encoding proteins involved in membrane transport
SM_b20989 Stomatin-like protein 1.26 2.42 1.21 8.27
SM_b20345 Efflux protein 0.99 3.98 0.65 2.38
SM_b20346 Efflux protein 1.31 4.32 0.85 2.42
SM_b20506 L-Arabinose transporter permease 0.94 2.29 1.20 2.04
SMc00563 Transporter 1.00 6.50 1.13 4.08
SMc00564 Transporter 0.80 4.59 1.22 3.21
SMc03167 Multidrug efflux system protein 1.40 5.57 0.97 3.10
SMc03168 Multidrug efflux system protein 2.21 5.77 0.87 2.95
SMc03825 Transporter 0.95 3.17 1.12 2.53
SM_b21432 Iron uptake ABC transporter substrate-binding protein
precursor
2.67 0.98 2.62 1.21
SMc03845 Conserved extracellular hypothetical protein 2.44 0.89 2.20 0.80
SMc02085 Biopolymer transport transmembrane protein 3.02 1.47 3.34 1.54
SMc02084 Biopolymer transport transmembrane protein 2.81 1.57 2.57 1.47
SMc04128 Heavy metal-transporting ATPase (Cd export) 0.11 0.27 0.23 0.32
SMc04167 Histidine-rich transporter transmembrane protein (Cd export) 0.26 0.46 0.45 0.67
SMc04175 Transmembrane protein (cation transport) 0.48 0.43 0.63 0.46
SM_b20903 Sugar uptake ABC transporter permease 0.59 0.48 0.51 0.41
SMc04317 Iron-binding periplasmic protein 0.58 0.37 0.51 0.37
SMc04454 ABC transporter ATP-binding protein 0.59 0.47 0.56 0.49
SMc01179 Spermidine export protein MdtJ 0.49 0.38 0.82 0.41
SMc01652 Spermidine/putrescine transport system substrate-binding
protein
0.59 0.80 0.42 0.35
SMc01510 Hemin importer ATP-binding subunit 2.46 1.96 2.74 2.15
SMc01511 Hemin transport system permease transmembrane protein 3.41 2.09 3.54 2.13
SMc01512 Hemin-binding periplasmic transmembrane protein 5.59 2.46 4.54 2.06
SMc01513 Hemin transport protein 5.04 3.05 4.74 2.80
SMc01657 Ferrioxamine B receptor precursor protein 3.36 2.11 3.27 2.06
SMc01659 Ferrichrome/ferrioxamine B periplasmic transporter 2.40 2.09 2.99 1.87
SMc03807 Ammonium transporter 1.44 4.21 1.79 3.21
SMc03900 Cyclic beta-1,2-glucan ABC transporter 3.08 2.69 2.54 2.20
SMc04350 Multidrug efflux system transmembrane protein 2.35 2.74 2.08 2.69
SMc04351 Transmembrane ATP-binding ABC transporter protein 2.62 2.89 2.70 2.87
SMc02514 Glycolipoprotein (GLP) periplasmic binding ABC transporter
protein
10.82 11.19 5.89 6.96
SMc02515 GLP hypothetical protein 4.37 5.51 2.15 2.78
SMc02516 GLP transport system permease ABC transporter protein 5.88 7.31 2.47 3.90
SMc02517 GLP transport system permease ABC transporter protein 5.46 5.85 2.37 2.93
SMc02518 GLP ABC transporter ATP-binding protein 4.54 4.27 2.56 2.73
SMc02519 GLP ABC transporter ATP-binding protein 3.87 3.29 2.54 2.24
SMc00265 Periplasmic binding protein 4.06 2.53 2.03 1.61
SMc02171 Periplasmic binding ABC transporter protein 2.00 2.54 1.58 1.87
SMc02219 Amino acid-binding periplasmic protein 1.00 2.49 2.10 3.82
SMc02616 Permease transmembrane protein 0.85 1.62 2.40 2.83
SMc02873 Periplasmic binding (signal peptide) ABC transporter protein 3.31 2.17 2.04 1.32
SMc03121 Periplasmic binding ABC transporter protein 2.50 2.20 1.60 1.38
SMc03167 Multidrug efflux system protein 1.40 5.57 0.97 3.10
SMc04202 Transmembrane protein 1.41 2.76 1.63 2.42
SM_b20117 Sugar transferase 1.10 3.16 1.41 4.33
SM_b20611 C4-dicarboxylate transporter DctA 3.88 2.38 2.25 1.68
SM_b20633 Sugar uptake ABC transporter permease 0.99 2.30 1.66 3.39
SM_b21604 Sugar uptake ABC transporter substrate-binding protein
precursor
8.07 16.69 8.27 4.83
(Continued on following page)
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tion factor) and FoxA-FhuFP-HmuSTUV proteins involved in
ferrioxamine transport. The genes coding for the redox proteins
thioredoxin and glutaredoxin as well as glutathione S-trans-
ferases, carbon monoxide dehydrogenase subunits, and enzymes
involved in fatty acid oxidation were also induced by the peptides.
DISCUSSION
Antimicrobial peptides are considered to be potential candidates
for a novel generation of antibiotics. In this study, potent antimi-
crobial properties of two nodule-specific cysteine-rich symbiotic
peptides were demonstrated, indicating the potential for their use
in the human/animal health care, plant protection, and food in-
dustry. Both cationic peptides NCR247 and NCR335 were able to
quickly kill a wide range of Gram-negative and Gram-positive
human/animal- and plant-pathogenic bacteria, thoughwith a dif-
ferent spectrum and from moderate to very high efficiency. This
ability further distinguishes NCRs and plant defensins, because
the latter ones are active against fungi (5, 15). At present, the
mode(s) of their action is not known, although the uptake of PI
(data not shown) indicated that the peptides changed the perme-
ability of the bacterial membranes. In addition, the reason for the
observed differences in the sensitivity of the strains is not known.
One possibility is that the two peptides do not recognize the same
bacterial target(s) or have different affinity toward a common tar-
get which might be present in different amounts or might be dif-
ferentially accessible in the various species. Another possible ex-
planation, which does not exclude the previous ones, is the
different sensitivity of the peptides toward the degrading activity
of the various proteases produced by the bacteria.
Since theMedicago genome codes for almost 600NCRpeptides
and roughly half of them are cationic, the nodules on the roots of
this species represent a treasure of potential antibiotics. One step
of this exploration is to test the target spectrum of the individual
peptides. Another important question is their mode of action.
How do these peptides kill bacteria? Do they simply destroy the
bacterial membranes or have specific targets that inhibit bacterial
functions? As a consequence, can the bacteria develop resistance
against these NCRs? This probability is less plausible if multiple
bacterial targets and pathways are affected.
Here, the potential targets and possible bacterial mechanisms
affected upon in vitro exposure to the cationic NCR peptides were
studied by transcriptome analysis of S. meliloti bacteria. Very few
peptide-specific gene expression changes could be observed, indi-
cating similar modes of action of the two peptides in this species.
The more cationic NCR335 peptide often induced more pro-
nounced up- or downregulation of the affected genes than
NCR247, mirroring its more potent antirhizobial activity. Treat-
ment of bacteria with the peptides resulted, within 10 min, in
downregulation of genes involved in basic cellular functions, such
as transcription-translation and energy production. We com-
pared these results with the limited data available on the effects of
other antimicrobial peptides and agents on other bacteria. A sim-
TABLE 1 (Continued)
Category and gene Putative function
Fold change
10 min 30 min
NCR247 NCR335 NCR247 NCR335
SMa0155 Tripartite ATP-independent periplasmic transporter (TRAP-
T) family
3.10 2.03 2.18 2.42
SMa0157 ABC transporter substrate-binding protein 6.15 4.53 3.27 2.18
SMc04243 High-affinity zinc uptake system membrane ABC transporter
protein
4.48 3.72 2.66 2.69
SMc04244 High-affinity zinc uptake system ATP-binding ABC
transporter protein
4.92 3.85 2.39 2.73
SMc04245 High-affinity zinc uptake system ABC transporter protein 18.43 14.64 4.35 5.63
SMc04246 Transmembrane signal peptide protein 3.98 3.21 2.77 2.07
Genes encoding stress-related proteins
SM_b21294 Hsp20 family heat shock protein 0.87 4.43 1.43 6.37
SM_b21295 Hsp20 family heat shock protein 0.88 4.21 1.30 5.27
SM_b22023 Molecular chaperone GroES 1.25 1.92 2.25 2.69
SMa1894 Methionine sulfoxide reductase B 1.34 2.39 1.37 2.56
SMa1896 Methionine sulfoxide reductase A 1.41 2.46 1.41 2.29
SMc00646 RNA polymerase factor sigma-32 2.16 2.44 2.23 2.25
SMc01106 Small heat shock protein 1.92 3.71 2.30 4.04
SMc01280 Protease 1.19 4.40 1.73 2.96
SMc01758 Chaperonin GroEL 1.10 2.36 1.54 2.72
SMc02433 ATP-dependent protease 1.94 4.85 2.92 5.10
SMc02575 ATP-dependent protease peptidase subunit 1.67 3.63 2.65 3.94
SMc02576 Acetyltransferase 1.59 2.41 2.12 3.26
SMc02858 Chaperone protein DnaJ 1.30 2.04 1.44 2.42
SMc02885 Methionine sulfoxide reductase A 2.18 3.20 2.23 3.27
SMc04040 Heat shock protein 2.06 3.88 3.45 5.46
Genes encoding proteins involved in modification of SH
groups
SMc01238 Glutathione S-transferase 0.89 1.86 2.04 6.91
SMc01443 Glutathione S-transferase 1.08 2.72 2.07 2.04
SMc02443 Glutaredoxin 1.50 2.37 2.03 2.79
SMc02761 Thioredoxin 2.06 4.60 2.12 3.82
Genes encoding proteins involved in glycine cleavage
SMc02047 Glycine cleavage system amino methyl transferase T 1.07 3.51 1.10 2.89
SMc02048 Glycine cleavage system protein H 1.18 3.06 1.21 2.76
SMc02049 Glycine dehydrogenase 1.17 2.31 1.12 2.11
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ilar downregulation of the transcription-translation machinery
has been observed in the Gram-positive S. aureus cells exposed to
daptomycin, an acidic cyclic lipopeptide antibiotic (16) known to
act via the obstruction of peptidoglycan biosynthesis and cell
membrane depolarization (17). The spermidine/putrescine trans-
porter-encoding genes were also inhibited; however, the expres-
sion of genes coding for the ATP synthetase subunits was not
affected by daptomycin treatment. Interestingly, the effects of the
membrane-depolarizing agent carbonyl cyanidem-chlorophenyl-
hydrazone (CCCP) on S. aureus were more similar to the NCR-
induced changes in Sinorhizobium, because CCCP caused the
downregulation of transcription-translation-related and ATP
synthetase genes. Though the Lactococcus bacteriocin nisin (18)
attacks also the peptidoglycan biosynthesis (19) and forms pores
in bacterial membranes (20), most of the gene expression changes
characteristic for daptomycin or CCCP treatments in S. aureus
were not observed or were less pronounced after challenging the
bacteria with this agent (17). In Streptococcus pneumoniae, nisin
induced moderate transcriptome variations. Similarly to NCR
peptides in S. meliloti, the human AMP, the cathelicidin-derived
linear LL-37 peptide (21), downregulated the S. pneumoniae genes
coding for RNA polymerases and helicases, ribosomal subunits,
and translation initiation and elongation factors (22). The effects
of AMPs and AMP-like peptides on gene expression are similar to
those caused by exposure to hydrogen peroxide, as was demon-
strated inBradyrhizobium japonicumby both fulminant shock and
prolonged exposure to this chemical (23). The upregulated genes
also show some similarities. In all cases, one can observe the in-
duction of genes encoding stress-related chaperonins, proteases,
methionine sulfoxide reductases, and sigma factors, as well as pro-
teins involved in oxidative stress response, mainly thioredoxins
but also glutaredoxins and glutathione S-transferases. To further
facilitate their adaptation to the stress conditions, the cells also
upregulated the expression of a large number of transcriptional
regulators and membrane transporters. In the case of the NCR
peptides, quite a few upregulated genes coding for transcription
factors were linked to upregulated genes/operons that code for
membrane transporter proteins, indicating possible concerted ac-
tions.
Based on these observations, it seems that the defensin-like
NCRpeptides, that in planta govern the differentiation of bacteria,
exert their antimicrobial activity in vitro by affecting bacterial cell
membranes, probably via forming pores and destroying themem-
brane potential. The impairment of membrane integrity was con-
firmed by detecting the uptake of the membrane-impermeable
dye PI after treatment of the cells with the peptides. The loss of
membrane integrity and membrane potential then might lead to
stress responses which include the slowdown of the cell metabo-
lism and the arresting of cell division. Higher concentrations of
and/or longer exposure to the stressormight then lead to the death
of the cells. In the plant cells, where different cocktails of cationic
as well as anionic and neutral NCRs are produced in the different
developmental stages, though most likely in much lower concen-
trations than in our experiments, the effects of peptides are less
dramatic. Rhizobia isolated from the nodules slowly take up pro-
pidium iodide, indicating membrane permeabilization; however,
in planta, the activity of peptides results only in the loss of cell
division capacity but not in the death of wild-type bacteria. Inter-
estingly, bacA mutant S. meliloti cells, which are more sensitive
toward the peptides, are quickly eliminated from the NCR-pro-
ducing plant cells as a result of the peptides’ antibacterial action
(24). This indicates that the plant cells produce peptides in an
amount that is close to the lethal concentrations. The bacterial
cells in symbiosis still had activemetabolism, but interestingly, the
expression of genes coding for proteins involved in transcription,
translation, and ATP synthesis was downregulated (25). In addi-
tion, the expression of a high number of membrane transporter-
coding genes changed in symbiosis; however, those involved in
iron acquisition were downregulated in contrast to their upregu-
lation we observed in vitro. The observed differences between the
in vitro and in planta effectsmight be the consequences of different
concentrations ofNCRs, the presence of various sets of peptides in
the plant cells, and/or the different environmental/physiological
conditions. The main mode of action of the peptides can be the
disruption of membrane potential or the opening of pores for
the transport of other peptides andmolecules, but they, especially
the acidic and neutral ones, might affect intracellular targets, as
well, such as the inhibition of the synthesis of storage compounds
like polyhydroxybutyrate (PHB) or the uncoupling of DNA syn-
thesis and cell division observed in symbiosis and in vitro by using
a low concentration of peptides (26). Getting a deeper insight into
the roles of the NCR molecules during the development of bacte-
ria in planta necessitates the (transcriptome) analysis of rhizobia
that can establish effective symbiosis both with NCR-producing
plants and with legumes that have no coding capacity for these
peptides.
In conclusion, it was demonstrated that plant-derived devel-
opmental regulators of bacteria can serve as antimicrobial agents
against a wide range of Gram-negative and Gram-positive bacte-
ria. Transcriptome analysis of cells treated with the peptides re-
vealed characteristic gene expression changes that are accompa-
nied with the stress caused by the disruption of bacterial
membrane potential, which can cause the death of bacterial cells.
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